SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biacore - BCOR -- Ignore unavailable to you. Want to Upgrade?

To: notyet who wrote (1)2/21/2000 1:49:00 PM
From: JEFF CHAPMAN  Read Replies (1) | Respond to of 7
 
No doubt about that. The thing I like about BCOR and HYSQ for that matter is that they offer technology solutions for a wide range of co's so they are a winner no matter what companies come out with a 'home-run' drug. This whole rush into biotech really will lift interest in the BCOR product line, imo, as these once cash starved small cap bio's can start spending more $, we'll see more IPO's, etc.



To: notyet who wrote (1)3/8/2000 5:27:00 PM
From: JEFF CHAPMAN  Read Replies (1) | Respond to of 7
 
Isn't it scary to see this stock move up 5 on only 20,000 shares! It did look like we were seeing some momentum come into the stock... Obviously any funds accumulating have to do so very slowly =)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News